Nu Skin Enterprises (NUS, NYSE) traded higher on an improved sales and profit outlook. Including a restructuring charge, December-quarter earnings per share are now expected to range from $0.37 to $0.39, versus a prior view of $0.32 to $0.34. Revenue should be $360 million to $365 million, up from previous...